Morning Seminar

MS3-10

Precision Hematology/Oncology: incorporating next-generation sequencing technologies into clinical practice

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Seishi Ogawa (Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan)

Sponsor: Medical Affairs, Astellas Pharma Inc.

Morning Seminar

MS3-11

Recent Topics in T-cell Lymphoma Treatment

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Kenji Ishitsuka (Department of Hematology and Immunology, Kagoshima University Hospital)

Sponsor: Celgene K.K.

Morning Seminar

MS3-12

The role of Immune checkpoint inhibitor in hematological malignancies

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Akihiro Tomita (Division of Hematology, Fujita Health University School of Medicine)

Sponsors: MSD K.K./TAIHO PHARMACEUTICAL CO., LTD.

Morning Seminar

MS3-13

Gaucher disease and Hematological diseases

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Hirohito Yamazaki (Division of Transfusion Medicine, Kanazawa University Hospital)

Sponsor: Sanofi K.K.

Morning Seminar

MS3-14

Contribution of azacitidine to lower-risk MDS

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.14 (Osaka International Convention Center, 8F 801-2)

Chair: Takahiro Suzuki (Department of Hematology, Kitasato University School of Medicine)

Sponsor: Nippon Shinyaku Co., Ltd.

Morning Seminar

MS3-15

EZH2 in the pathogenesis and targeted therapy of B-cell lymphoma

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.15 (Osaka International Convention Center, 7F 701-2)

Chair: Toshio Kitamura (Division of Cellular Therapy/Division of Stem Cell Signaling The Institute of Medical Science, The University of Tokyo)

Sponsor: Medical HQs, Eisai Co., Ltd.

Luncheon Seminar

LS3-1

New Treatment Strategies for R/R ALL
～ Blinatumomab:Bispecific T-Cell Engager(BiTE®) as new immunotherapy ～

Sun. Oct 14, 2018 11:45 AM - 12:30 PM No.1 (Osaka International Convention Center, 5F Main Hall)

Chair: Yukio Kobayashi (International University of Health and Welfare, Mita Hospital)

Sponsors: Amgen Astellas BioPharma K.K./Astellas Pharma Inc.

Luncheon Seminar

LS3-3

Therapeutic Targeting of Acute Myeloid Leukemia Stem Cells

Sun. Oct 14, 2018 11:45 AM - 12:30 PM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: Koichi Akashi (Dept. of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University, Japan)

Sponsor: AbbVie GK

Luncheon Seminar

LS3-4

Future perspective of allogeneic hematopoietic transplantation for acute myeloid leukemia

Sun. Oct 14, 2018 11:45 AM - 12:30 PM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Shinichiro Okamoto (Division of Hematology Department of Internal Medicine, Keio University School of Medicine)

Sponsor: Fuji Pharma Co., Ltd

Luncheon Seminar

LS3-5

Clinical usefulness of gene mutation analysis as a prognostic factor in acute myeloid leukemia 2018

Sun. Oct 14, 2018 11:45 AM - 12:30 PM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Hitoshi Kiyoi (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)

Sponsor: Daiichi Sankyo Co., Ltd.